<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02423551</url>
  </required_header>
  <id_info>
    <org_study_id>15-12HC</org_study_id>
    <nct_id>NCT02423551</nct_id>
  </id_info>
  <brief_title>MRE Consumption and Gut Health</brief_title>
  <official_title>Effects of Meal, Ready-to-Eat (MRE) Consumption on Gut Health</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>United States Army Research Institute of Environmental Medicine</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>United States Army Research Institute of Environmental Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to determine the impact of consuming MREs as the sole source
      of subsistence for 21 days on gut bacteria community composition and gut health. Up to 80
      free-living adults will be randomized to consume their usual diet or only MREs for 21
      consecutive days. MREs will be provided by the Military Nutrition Division, US Army Research
      Institute of Environmental Medicine (USARIEM). Fecal, urine and blood samples will be
      collected periodically before, during and after the intervention to measure gut barrier
      integrity, gut bacteria community composition, and markers of gut health, inflammation, and
      nutritional status.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 2015</start_date>
  <completion_date type="Actual">February 2017</completion_date>
  <primary_completion_date type="Actual">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in gut barrier integrity</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>Urine excretion of saccharide probes; circulating zonulin, intestinal fatty acid binding protein, claudin-3, lipopolysaccharide and GLP2 concentrations</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in gut microbiota composition</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>16S rRNA gene sequencing</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in C-reactive protein concentrations</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>Serum C-reactive protein</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in TNF-alpha concentrations</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>Serum TNF-alpha</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in interleukin-6 concentrations</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>Serum IL-6</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in lipopolysaccharide concentrations</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>Plasma LPS</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in iron status</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>Blood ferritin, soluble transferrin receptor, hemoglobin, hematocrit</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in vitamin D status</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>Blood 25-hydroxyvitamin D, 1,25-dihydroxyvitamin D, parathyroid hormone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in B-vitamin status</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>Blood folate, vitamin B12, homocysteine</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in nutritional status</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>Blood prealbumin</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in calcium absorption</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>Urine calcium</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in zinc status</measure>
    <time_frame>Baseline to 10 days, 21 days and 31 days</time_frame>
    <description>Blood zinc, zinc receptor expression</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">71</enrollment>
  <condition>Gastrointestinal Tract</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual diet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MRE</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRE consumption</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>MRE</intervention_name>
    <description>MRE consumption</description>
    <arm_group_label>MRE</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  BMI &lt;/= 30

        Exclusion Criteria:

          -  Use of antiobiotcs within 3 months of study participation

          -  Use of pro- or prebiotic supplements within 2 weeks of study participation

          -  Vegetarian diets

          -  Use of laxatives, stool softeners, or anti-diarrheal medications at least once a week.

          -  Fewer than 4 bowel movements, on average, per week

          -  History of gastrointestinal disease

          -  Colonoscopy within 3 months of study participation

          -  Food allergies or aversions or other issues with foods that would preclude MRE
             consumption, including gluten, milk, nuts, or eggs.

          -  Use non-steroidal anti-inflammatory medications (NSAIDs) or antihistamine prescribed
             by a physician or clinician, or unwillingness to discontinue the use of these
             substances during the study.

          -  Actively trying to lose weight

          -  Pregnant or lactating

          -  Recent blood donation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>62 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>USARIEM</name>
      <address>
        <city>Natick</city>
        <state>Massachusetts</state>
        <zip>01760</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 14, 2015</study_first_submitted>
  <study_first_submitted_qc>April 17, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2015</study_first_posted>
  <last_update_submitted>April 16, 2018</last_update_submitted>
  <last_update_submitted_qc>April 16, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">April 18, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>United States Army Research Institute of Environmental Medicine</investigator_affiliation>
    <investigator_full_name>James Philip Karl</investigator_full_name>
    <investigator_title>Research Dietitian</investigator_title>
  </responsible_party>
  <keyword>Gut microbiota</keyword>
  <keyword>Intestinal permeability</keyword>
  <keyword>Gut barrier integrity</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

